COMMUNIQUÉS West-GlobeNewswire

FibroGen to Report Second Quarter 2019 Financial Results on Thursday, August 8, 2019
02/08/2019
SAN FRANCISCO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced that it will report second quarter 2019 financial results on Thursday, August 8, 2019 after market close, and will host a [...]
MannKind Corporation to Hold 2019 Second Quarter Financial Results Conference Call on August 7, 2019
01/08/2019
WESTLAKE VILLAGE, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) will release its 2019 second quarter and year-to-date financial results and its management will host a conference call to [...]
Kane Biotech Announces New Funding Granted from CanExport Program
01/08/2019
WINNIPEG, Manitoba, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
ARCA biopharma Announces Second Quarter 2019 Financial Results and Provides Corporate Update
01/08/2019
FDA SPA Agreement for Phase 3 atrial fibrillation trial (PRECISION-AF) amended to expand patient population to include heart failure patients with preserved ejection fraction (HFpEF) PRECISION-AF clinical trial [...]
Eidos Therapeutics Reports Second Quarter 2019 Financial Results
01/08/2019
SAN FRANCISCO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq: EIDX), today reported its financial results for the second quarter ended June 30, 2019 and provided an update on the company’s [...]
Osmotica Pharmaceuticals plc to Provide Second Quarter 2019 Business and Financial Update on August 8, 2019
01/08/2019
BRIDGEWATER, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that the Company will release [...]
IntelGenx to Report Second Quarter 2019 Financial Results on August 8, 2019 – Conference Call to Follow
01/08/2019
SAINT LAURENT, Quebec, Aug. 01, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its second quarter 2019 financial [...]
Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019
01/08/2019
Conference Call and Webcast Scheduled for Monday, August 12 at 4:30 p.m. Eastern Time YARDLEY, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, [...]
The Ensign Group Acquires California Senior Living Community
01/08/2019
SAN JUAN CAPISTRANO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]
The Ensign Group Acquires Arizona Hospice Agency
01/08/2019
SAN JUAN CAPISTRANO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]
Otonomy Reports Second Quarter 2019 Financial Results and Provides Corporate Update
01/08/2019
Clinical-stage programs on track with results expected from three trials in 2020 Current capital funds operations into 2021 Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE [...]
The Ensign Group Acquires Utah Skilled Nursing Facility
01/08/2019
SAN JUAN CAPISTRANO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]
The Ensign Group Reports Second Quarter Results
01/08/2019
Conference Call and Webcast scheduled for tomorrow, August 2, 2019 at 10:00 am PT MISSION VIEJO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group [...]
Fulgent Genetics Receives Laboratory Permit and Genetic Test Approval from New York State Department of Health
01/08/2019
TEMPLE CITY, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, [...]
Globus Medical Reports Second Quarter 2019 Results
01/08/2019
AUDUBON, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2019. Worldwide [...]
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019
01/08/2019
SEATTLE, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it will report financial results for the second quarter of 2019 after market close on Tuesday, August 13, 2019. [...]
Guardant Health to Participate in Upcoming Investor Conferences
01/08/2019
REDWOOD CITY, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/08/2019
BOSTON, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
Synthorx Reports Second Quarter Financial Results
01/08/2019
SAN DIEGO, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today reported financial results [...]

Pages